Home > Financial Ratios > TRIDENT LIFELINE

TRIDENT LIFELINE
Core EBITDA Growth

    Back to All Ratios
TRIDENT LIFELINE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for TRIDENT LIFELINE
Please provide your vote to see the results

TRIDENT LIFELINE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 38.82124.29-

What is the latest Core EBITDA Growth ratio of TRIDENT LIFELINE ?

The latest Core EBITDA Growth ratio of TRIDENT LIFELINE is 38.82 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202438.82
Mar2023124.29
Mar2022-

How is Core EBITDA Growth of TRIDENT LIFELINE Trending?

Years Core EBITDA Growth % Change
Mar2024 38.82
-68.77
Mar2023 124.29
0
Mar2022 0 -

Other Financial Ratios of TRIDENT LIFELINE


Compare Core EBITDA Growth ratio of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹340.0 Cr 6.6% 8.6% 73.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,383.0 Cr 2.6% -5.1% -6.4% Stock Analytics
DIVIS LABORATORIES ₹162,026.0 Cr -0.5% -10.1% 21.8% Stock Analytics
CIPLA ₹126,159.0 Cr 4.7% 4.8% -4.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,450.0 Cr 0.6% 5.2% 8.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,536.0 Cr 4.3% -0.7% -11.4% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

6.6%

8.6%

73.9%

SENSEX

-0%

-2.1%

1.1%


You may also like the below Video Courses